ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,582Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 244

$934K Total Retail Price of All Prescriptions

Rank: 13 out of 244

373 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 373 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

17% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 18,770 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
WARFARIN SODIUM 1,239 1,223 1 8
FUROSEMIDE 1,083 1,030 2 3
LEVOTHYROXINE SODIUM 922 860 3 4
METOPROLOL TARTRATE 686 685 4 5
SIMVASTATIN 650 610 5 1
LISINOPRIL 641 608 6 7
OMEPRAZOLE 535 525 7 6
ALBUTEROL SULFATE 450 447 8 55
POTASSIUM CHLORIDE 364 351 9 25
SERTRALINE HCL 358 354 10 22
AMLODIPINE BESYLATE 327 317 11 2
MIRTAZAPINE 319 318 12 13
LANTUS 300 296 13 30
IPRATROPIUM-ALBUTEROL 272 272 14 54
TAMSULOSIN HCL 251 246 15 20
HYDROCODONE-ACETAMINOPHEN 228 227 S3 16 46
DONEPEZIL HCL 220 210 17 9
QUETIAPINE FUMARATE 206 177 18 31
TAMIFLU 205 195 19 99
METOPROLOL SUCCINATE 205 204 19 11
ADVAIR DISKUS 203 197 21 40
ALLOPURINOL 194 179 22 57
LEVOFLOXACIN 186 185 23 111
RISPERIDONE 179 165 24 36
NYSTOP 175 175 25 90
METFORMIN HCL 172 169 26 10
FINASTERIDE 171 171 27 52
NITROGLYCERIN PATCH 169 169 28 163
PREDNISONE 169 169 28 43
GABAPENTIN 167 151 30 14
CITALOPRAM HBR 148 139 31 15
ATENOLOL 147 147 32 18
NAMENDA 147 138 32 19
CEPHALEXIN 145 136 34 107
CARBIDOPA-LEVODOPA 134 133 35 41
CARVEDILOL 131 128 36 23
DIVALPROEX SODIUM 129 117 37 59
POLYETHYLENE GLYCOL 3350 126 125 38 33
NOVOLIN N 124 124 39 171
NYSTATIN 123 121 40 83
SPIRIVA 122 111 41 66
LATANOPROST 120 116 42 79
ISOSORBIDE MONONITRATE ER 115 115 43 44
SPIRONOLACTONE 110 110 44 78
GLIPIZIDE 110 110 44 42
TRAZODONE HCL 109 109 46 35
ISOSORBIDE DINITRATE 109 109 46 148
NOVOLOG 107 107 48 75
CYMBALTA 107 94 48 56
HYDROCHLOROTHIAZIDE 106 104 50 12
CLOPIDOGREL 105 102 51 29
LEVETIRACETAM 102 89 52 39
KLOR-CON M20 95 95 53 98
ATORVASTATIN CALCIUM 90 84 54 17
DIGOXIN 90 90 54 45
SEROQUEL 86 77 56 92
DILTIAZEM 24HR CD 82 82 57 136
TRAVATAN Z 80 71 58 116
ERYTHROMYCIN 79 78 59 315
PANTOPRAZOLE SODIUM 79 78 59 61
HALOPERIDOL 77 76 61 105
HYDROCORTISONE 76 76 62 196
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 75 63 125
LOSARTAN POTASSIUM 74 74 64 16
ESCITALOPRAM OXALATE 72 72 65 60
LIDODERM 70 62 66 69
BACLOFEN 68 43 67 104
OLANZAPINE 67 67 68 85
NOVOLIN R 64 64 69 145
PHENYTOIN SODIUM EXTENDED 62 60 70 190
PLAVIX 61 61 71 38
LIDOCAINE HCL VISCOUS 61 0 71 352
DIOVAN 60 59 73 37
NYSTATIN-TRIAMCINOLONE 60 60 73 76
CEFUROXIME 58 58 75 358
KETOCONAZOLE 58 58 75 197
AMOX TR-POTASSIUM CLAVULANATE 58 58 75 133
CEFTRIAXONE 57 57 78 251
LANTUS SOLOSTAR 57 42 78 91
FENTANYL 56 56 S2 80 108
LIDOCAINE HCL 54 53 81 200
TRAMADOL HCL 51 51 82 53
AMOXICILLIN 51 51 82 299
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.